Liquid Biopsy for Minimal Residual Disease Detection in Head and Neck Squamous Cell Carcinoma (LIONESS): A personalized cell-free tumor DNA analysis for patients with HNSCC | NeoGenomics Laboratories

Publication date

Mon, 06/06/2022 - 12:00

Year

Subtitle

ASCO 2022

File

Liquid_bIOpsy_for_miNimal_rESidual_diSease_detection_in_Head_and_Neck_Squamous_Cell_Carcinoma_%28LIONESS%29-A_personalized_cell-free_tumor_DNA_analysis_for_patients_with_HNSCC.pdf (2.13 MB)

Division